Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19841453 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Modification Of Disease Outcome In COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: fluticasone 500 mcg;   Drug: fluticasone 500 mcg + salmeterol 50 mcg

Indicates status has not been verified in more than two years